Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jul-Aug;69(4):545-550.
doi: 10.1016/j.ihj.2017.07.004. Epub 2017 Jul 5.

Atrial fibrillation and hyperthyroidism: A literature review

Vivek Reddy  1 , Wael Taha  2 , Shanker Kundumadam  3 , Mazhar Khan  4
Affiliations
Review

Atrial fibrillation and hyperthyroidism: A literature review

Vivek Reddy et al. Indian Heart J. 2017 Jul-Aug.

Abstract

Atrial fibrillation is the most common arrhythmia worldwide with increasing frequency noted with age. Hyperthyroidism is a well-known cause of atrial fibrillation with a 16%-60% prevalence of atrial fibrillation in patients with known hyperthyroidism Ross et al. (2016). While hyperthyroidism as a causative factor of atrial fibrillation is well established, this literature review aims to answer several questions on this topic including: 1. The relationship of atrial fibrillation to hyperthyroidism 2. Atrial fibrillation as a predictor of hyperthyroidism 3. The pathophysiology of thyrotoxic atrial fibrillation 4. Subclinical hyperthyroidism and the relationship with atrial fibrillation 5. Cardioversion and Catheter ablation of hyperthyroid patients with atrial fibrillation 6. Thrombotic risk of hyperthyroid patients with atrial fibrillation 7. Management of Thyrotoxic Atrial fibrillation 8. Pharmacological rhythm control in patients with hyperthyroidism and atrial fibrillation 9. Treatment of Hyperthyroidism to prevent atrial fibrillation 10. Clinical Implications of Hyperthyroidism and Atrial Fibrillation.

Keywords: Atrial fibrillation; Hyperthyroidism; Pathogenesis.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
A figure illustrating the pathogenesis of atrial fibrillation in hyperthyroidism.
See this image and copyright information in PMC

References

    1. Ross D.S., Burch H.B., Cooper D.S. American thyroid association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016;26(10):1343–1421. [2016] - PubMed
    1. Hollowell J.G., Staehling N.W., Flanders W.D. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): national health and nutrition examination survey (NHANES III) J Clin Endocrinol Metab. 2002;87(2):489–499. - PubMed
    1. Mammen J.S., McGready J., Oxman R., Chia C.W., Ladenson P.W., Simonsick E.M. Thyroid hormone therapy and risk of thyrotoxicosis in community-resident older adults: findings from the baltimore longitudinal study of aging. Thyroid. 2015;25(9):979–986. - PMC - PubMed
    1. Krahn A.D., Klein G.J., Kerr C.R. How useful is thyroid function testing in patients with recent-onset atrial fibrillation? The Canadian Registry of Atrial Fibrillation Investigators. Arch Intern Med. 1996;156(19):2221–2224. - PubMed
    1. Frost L., Vestergaard P., Mosekilde L. Hyperthyroidism and risk of atrial fibrillation or flutter: a population-based study. Arch Intern Med. 2004;164(15):1675–1678. - PubMed